These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37642974)
1. Pharmacological evaluations of amide carboxylates as potential anti-Alzheimer agents: anti-radicals, enzyme inhibition, simulation and behavioral studies in animal models. Mahnashi MH; Ali S; M Alshehri O; Almazni IA; Asiri SA; Sadiq A; Zafar R; Jan MS J Biomol Struct Dyn; 2023 Aug; ():1-20. PubMed ID: 37642974 [TBL] [Abstract][Full Text] [Related]
2. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches. Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447 [TBL] [Abstract][Full Text] [Related]
3. Zinc metal carboxylates as potential anti-Alzheimer's candidate: Zafar R; Zubair M; Ali S; Shahid K; Waseem W; Naureen H; Haider A; Jan MS; Ullah F; Sirajuddin M; Sadiq A J Biomol Struct Dyn; 2021 Feb; 39(3):1044-1054. PubMed ID: 32013770 [TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease. Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518 [TBL] [Abstract][Full Text] [Related]
15. Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives. Pervaiz A; Jan MS; Hassan Shah SM; Khan A; Zafar R; Ansari B; Shahid M; Hussain F; Ijaz Khan M; Zeb A; Mukarram Shah SM J Biomol Struct Dyn; 2022 May; ():1-14. PubMed ID: 35507043 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modeling and neuroprotective effects of a new framework of cholinesterase inhibitors for Alzheimer's disease. Zanon VS; Lima JA; Amaral RF; Lima FRS; Kitagawa DAS; França TCC; Vargas MD J Biomol Struct Dyn; 2021 Oct; 39(16):6112-6125. PubMed ID: 32715924 [TBL] [Abstract][Full Text] [Related]
17. Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches. Anwar S; Rehman W; Hussain R; Khan S; Alanazi MM; Alsaif NA; Khan Y; Iqbal S; Naz A; Hashmi MA Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513821 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases. Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278 [TBL] [Abstract][Full Text] [Related]
19. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti-Alzheimer agents. Eissa KI; Kamel MM; Mohamed LW; Galal MA; Kassab AE Drug Dev Res; 2022 Sep; 83(6):1394-1407. PubMed ID: 35749685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]